https://www.selleckchem.com/pr....oducts/ro5126766-ch5
This study provides detailed information on perioperative complication and postoperative course, which is essential for patient consenting.An effective vaccine would be a valuable tool for malaria control and elimination; however, the leading malaria vaccine in development, RTS,S/AS01, provided only partial protection in a Phase 3 trial. R21 is a next-generation RTS,S-like vaccine. We have previously shown in mice that R21 administered in Matrix-M is highly immunogenic, able to elicit complete protection against sporozoite c
Like
Comment
Share
